DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+21.45%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.75B
AUM Growth
+$5.75B
(+6.1%)
Cap. Flow
+$243M
Cap. Flow
% of AUM
4.22%
Top 10 Holdings %
Top 10 Hldgs %
51.71%
Holding
447
New
223
Increased
64
Reduced
46
Closed
77
Top Buys
| 1 |
BioNTech
BNTX
|
$52.5M |
| 2 |
Kyverna Therapeutics
KYTX
|
$36.3M |
| 3 |
Perspective Therapeutics
CATX
|
$33.5M |
| 4 |
Larimar Therapeutics
LRMR
|
$32.6M |
| 5 |
Surgery Partners
SGRY
|
$32.3M |
Top Sells
| 1 |
Viking Therapeutics
VKTX
|
$66.9M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$64M |
| 3 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$62.6M |
| 4 |
Baxter International
BAX
|
$57.8M |
| 5 |
Neurocrine Biosciences
NBIX
|
$28.4M |
Sector Composition
| 1 | Healthcare | 88.87% |
| 2 | Industrials | 0.71% |
| 3 | Technology | 0.31% |
| 4 | Consumer Discretionary | 0.26% |
| 5 | Financials | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Biomea Fusion
BMEA
$114M
| – | – |
-11,206
| Closed | -$163K |
|
427
Box
BOX
$4.69B
| – | – |
-9,651
| Closed | -$247K |
|
|
CIM
428
Chimera Investment
CIM
$1.15B
| – | – |
-19,205
| Closed | -$95.8K |
|
429
CareTrust REIT
CTRE
$7.53B
| – | – |
-14,554
| Closed | -$326K |
|
430
Dominion Energy
D
$50.3B
| – | – |
-4,495
| Closed | -$211K |
|
431
DaVita
DVA
$9.72B
| – | – |
-3,201
| Closed | -$335K |
|
432
DexCom
DXCM
$30.9B
| – | – |
-3,640
| Closed | -$452K |
|
433
Euronet Worldwide
EEFT
$3.72B
| – | – |
-3,817
| Closed | -$387K |
|
434
FMC
FMC
$4.63B
| – | – |
-5,500
| Closed | -$347K |
|
435
Forward Air
FWRD
$923M
| – | – |
-3,294
| Closed | -$207K |
|
436
Geron
GERN
$893M
| – | – |
-35,675
| Closed | -$75.3K |
|
437
Huntington Bancshares
HBAN
$25.7B
| – | – |
-14,701
| Closed | -$187K |
|
438
Hallador Energy
HNRG
$703M
| – | – |
-28,506
| Closed | -$252K |
|